What is BASi?
Operating as a critical node in the healthcare ecosystem, BASi provides comprehensive laboratory and pathology services that bridge the gap between specimen collection and clinical decision-making. Through its integration with Northwest Pathology, the company offers a sophisticated suite of services, including histology, immunohistochemistry, and molecular testing. With a robust delivery network and advanced laboratory information systems, BASi serves a diverse clientele ranging from regional hospitals to outpatient clinics across 37 states. The company's market position is defined by its ability to provide high-precision diagnostic data, supported by a team of expert pathologists, which is essential for modern, evidence-based medical practice.
How much funding has BASi raised?
BASi has raised a total of $15.2M across 3 funding rounds:
Stock Offering
$10M
Debt
$5M
Debt
$150K
Stock Issuance/Offering (1997): $10M, investors not publicly disclosed
Debt (2020): $5M led by PPP
Debt (2024): $150K supported by BayFirst National Bank
Key Investors in BASi
BayFirst National Bank
A financial institution providing commercial banking solutions and capital support to growing enterprises.
PPP
Public-Private Partnership
Undisclosed Investor
An undisclosed investor participating in the historical stock issuance round to support long-term corporate development.
What's next for BASi?
With the recent influx of capital, BASi is well-positioned to accelerate its operational efficiency and technological integration. The strategic focus will likely center on enhancing its laboratory information system (LIS) to further streamline electronic medical record interfacing, a critical requirement for modern healthcare providers. Furthermore, the company is expected to deepen its investment in specialized testing menus, particularly in molecular diagnostics and women's health, to maintain its competitive edge. As the firm continues to scale its reach, the emphasis will remain on maintaining the high-touch, expert-led consultation model that has become its hallmark, ensuring that its diagnostic services remain indispensable to the hospitals and clinics it supports.
See full BASi company page
